Sevikar HCT 40mg/10mg/12.5mg 28 tablets — Made in Germany — Free Delivery

Product description 

• adjunctive therapy (prescribed to patients whose blood pressure is not sufficiently controlled by the combination of olmesartan medoxomil and amlodipine as a two-component drug);
• replacement therapy (prescribed as an alternative therapy in adult patients whose blood pressure is normally controlled using a combination of olmesartan medoxomil, amlodipine and hydrochlorothiazide as two-component preparations (olmesartan medoxomil and amlodipine or olmesartan medoxomil and hydrochlorothiazide) and single-component preparations (hydrochlorothiazide or amlodipine).

Compound

Contraindications

• hypersensitivity to active substances, to dihydropyridine derivatives or to sulfanilamide substances (since hydrochlorothiazide is a sulfanilamide preparation) or to any of the excipients;
• severe renal dysfunction;
• persistent hypokalemia, hypercalcemia, hyponatremia and clinically significant hyperuricemia;
• severe liver dysfunction, cholestasis and obstructive diseases of the bile ducts;
• II and III trimester of pregnancy;
• the combined use of the preparation  "Sevikar HCT" and preparations containing aliskiren is contraindicated in patients with diabetes mellitus or impaired renal function (GFR < 60 ml / minute / 1.73 m2);
• due to the content of amlodipine as an active ingredient in the preparation, the preparation "Sevikar  HCT" is contraindicated in patients with: shock (including cardiogenic shock), severe hypotension, impaired blood outflow from the left ventricle (for example, severe aortic stenosis), hemodynamically unstable heart failure after acute myocardial infarction.

Mode of application

Application features